Walgreens Boots Alliance plans to apply for certification to dispense medication that can induce abortions, after a federal rule change Tuesday expanding the ways patients can get the pills.
“We intend to become a certified pharmacy under the program,” said Walgreens, which is based in Deerfield, in a statement Wednesday. “We are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws.”The statement came a day after the U.S.
Since the change, many have been watching Walgreens and other large retail pharmacy chains to see if they would seek certification. Axios reported Wednesday evening that CVS Health also plans to seek certification.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Workforce Solutions hosts annual winter food drive benefiting the SA Food BankWorkforce Solutions Alamo is hosting its annual winter food drive benefitting the San Antonio Food Bank this month.
Read more »
More retail pharmacies can now offer abortion pills after FDA rule changeThe Food and Drug Administration on Tuesday finalized a rule change that broadens...
Read more »
Walgreens Will Sell The Abortion Pill, Pharmacy SaysThe chain says it will sell the abortion pill mifepristone in certain stores, a day after the FDA changed its rules to allow retail pharmacies to fill prescriptions.
Read more »
Walgreens plans to start offering abortion pills, pharmacy confirmsWalgreens plans to start offering abortion pills, following the FDA's announcement that it will allow retail pharmacies to offer the drug, the company told Axios.
Read more »
Walgreens Becomes First U.S. Pharmacy Chain to Say It Will Sell Abortion PillWalgreens says it will sell the abortion pill, a day after the FDA changed its rules to allow retail pharmacies to fill prescriptions for the controversial drug
Read more »
FDA set to make decision on experimental Alzheimer's drug this weekThe Food and Drug Administration is expected to decide by Friday whether to grant accelerated approval for Eisai and Biogen's experimental Alzheimer's drug, lecanemab.
Read more »